EP0732332A1 — Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
Assigned to Aventis Pharmaceuticals Inc · Expires 1996-09-18 · 30y expired
What this patent protects
This invention relates to compounds of the formula I wherein X is hydrogen, halogen, hydroxy, (C 1 -C 6 )alkoxy, amino or trifluoromethyl; and Y is -CN or -NR 1 R 2 ; where l is an integer of 1 or 2; m is an integer of 0, 1 or 2; n is an integ…
USPTO Abstract
This invention relates to compounds of the formula I wherein X is hydrogen, halogen, hydroxy, (C 1 -C 6 )alkoxy, amino or trifluoromethyl; and Y is -CN or -NR 1 R 2 ; where l is an integer of 1 or 2; m is an integer of 0, 1 or 2; n is an integer of 2, 3 or 4, except when Y is CN, in which case n can also be 1; R 1 is hydrogen, (C 1 -C 6 )alkyl or (C 1 -C 6 )alkylcarbonyl; R 2 is hydrogen, (C 1 -C 10 )alkylcarbonyl, (C 3 -C 12 )cycloalkylcarbonyl, hydroxy-(C 1 -C 6 )alkylcarbonyl, phenylcarbonyl, thienylcarbonyl or benzothienylcarbonyl; or R 1 and R 2 together with nitrogen atom to which they are attached form the ring where A is C = O or CH 2 ; and B is C = O, CHOH, CH 2 or CH 2 CH 2 ; and Z is hydrogen, halogen, hydroxy, (C 1 -C 6 )alkoxy, amino or trifluoro; and pharmaceutically acceptable acid addition salts thereof, pharmaceutical compositions thereof and their use for the treatment of psychoses.
Drugs covered by this patent
- Rexulti (BREXPIPRAZOLE) · Otsuka
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.